Advertisement

Topics

InVivo Communications Company Profile

02:04 EST 10th December 2018 | BioPortfolio

Combining our expertise in communication, healthcare and financial markets, we enable our clients to communicate the true value to biotechnology investors

Biotech companies face communication challenges as their business is often perceived as high risk. The key for building trust and bridging the valuation gap between the biotech companies and the financial market is to effectively communicate the true values. In order to succeed, the values do not only need to be identified but also conveyed in an effective way.

InVivo Communications specializes in strategic financial communication for European biotechnology companies. Represented in Stockholm, London and Zürich, we communicate locally but on a global basis.

We offer deep experience and knowledge in communication, healthcare and financial markets. By combining these skills we work with our clients closely and on a long-term basis to identify, package and convey their investments stories to the financial and media community.



Location

Engelbrektsplan 2PO Box 3104
Stockholm
SE-103 62
Sweden

Contact

Phone: 46 8-679 49 50
Fax: 46 8-679 49 59
Email: info@invics.se


News Articles [172 Associated News Articles listed on BioPortfolio]

InVivo Therapeutics: Fällt jetzt der +1.777%-Startschuss?

InVivo Therapeutics (WKN: A2JH81) ist aktuell mit Sicherheit einer der heißesten Picks im Nano-Cap-Universum, denn der bevorstehenden Start der lang erwarteten Inspire 2.0-Studie dürfte die Aktie m....

Invivo Therapeutics: Hoffnung für Querschnittsgelähmte - und Aktionäre

InVivo Therapeutics (US-Kürzel: NVIV, Schlusskurs 09.11.18: 1,99 USD) ist aktuell mit Sicherheit einer der heißesten Picks im Nano-Cap-Universum, denn der bevorstehenden Start der lang erwarteten I....

InVivo Therapeutics announces pricing of $13.2M offering

A public stock offering has been priced by InVivo Therapeutics in hopes of raising $13.2 million in gross proceeds.  -More- 

Offering pulls in about $15.2M for InVivo Therapeutics

A public offering of shares and warrants brought in about $15.2 million for InVivo Therapeutics.  -More- 

InVivo Analytics Announces Publication of Research Validating Automated Data Analysis in Preclinical Imaging

NEW YORK (PRWEB) October 18, 2018 InVivo Analytics® Inc., announces the publication of a research study demonstrating the compa...

InVivo Therapeutics to Present at the LD Micro Main Event on Tuesday December 4th, 2018

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the LD Micro Main Event on Tue...

InVivo Therapeutics Announces Publication of Neuro-Spinal Scaffold Preclinical Data in Peer-Reviewed Journal Biomaterials

- Supports INSPIRE clinical investigation of the Neuro-Spinal Scaffold - InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV), a research and clinical-stage biomaterials an...

Communications Power Industries Expands Antenna Business With Acquisition Of Orbital Systems ...

PALO ALTO, Calif., Aug. 21, 2018 /PRNewswire/ -- Communications & Power Industries (CPI) has acquired the related companies Orbital Systems, Ltd. and Quorum Communications, Inc. Read more...

PubMed Articles [28 Associated PubMed Articles listed on BioPortfolio]

PrEP Communications Accelerator: a digital demand creation tool for sub-Saharan Africa.

Strategic communications are critical for successful market introduction of oral pre-exposure prophylaxis (PrEP). This paper focuses on the OPTIONS Consortium's approach to developing the PrEP Communi...

XXXII Reunion da Sociedade Galega de Neuroloxia. Communications.

Newborn Screening and Health Communications.

Multi-Spectral Fluorescence Imaging of Colon Dysplasia InVivo Using a Multi-Spectral Endoscopy System.

To develop a molecular imaging endoscopic system that eliminates tissue autofluorescence and distinguishes multiple fluorescent markers specifically on the cancerous lesions.

Erratum: Publisher Correction: genomes reveal adaptive evolution of functions related to coral-dinoflagellate symbiosis.

[This corrects the article DOI: 10.1038/s42003-018-0098-3.].

Clinical Trials [19 Associated Clinical Trials listed on BioPortfolio]

The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer

This study intends to carry out a prospective, randomized controlled trial to research and development a new invivo microscopy based on the technology which is combined with high-definitio...

Multi-level Communications and Access Strategies to Improve the Food Environment

The overarching goal of B'More Healthy Retail Rewards (BHRR) is to develop, implement, and evaluate a pilot multi-level communications and pricing intervention to improve access to and con...

HERrespect Evaluation

This study evaluates whether a factory wide intervention, HERrespect, can reduce female garment workers' experiences of intimate partner violence, and experience and/or witnessing of viole...

Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer

The goal of this proposal is to determine whether a hand-held confocal microscopy probe may perform better than standard methods in detecting cancer or pre-cancerous abnormalities of the c...

Improving the Outpatient Referral Process With Electronic Communications

An electronic referral application will be developed and integrated into the existing outpatient information system. The primary goal of this software is to improve the quality and coordi...

Companies [435 Associated Companies listed on BioPortfolio]

InViVo Communications Inc.

InViVo Communications Inc. is a leading healthcare new media company. Our boutique develops specialized communication programs and products for many biotechnology, global pharmaceutical and medical de...

Invivo

Invivo is the pioneer in innovative RF coils to increase image quality and improve diagnostic confidence. We are the world leader in MRI monitoring, providing accurate vital signs for improved patient...

InVivo Communications

Combining our expertise in communication, healthcare and financial markets, we enable our clients to communicate the true value to biotechnology investors Biotech companies face communication challeng...

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

InVivo Therapeutics Corporation

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in indiv...

More Information about "InVivo Communications" on BioPortfolio

We have published hundreds of InVivo Communications news stories on BioPortfolio along with dozens of InVivo Communications Clinical Trials and PubMed Articles about InVivo Communications for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InVivo Communications Companies in our database. You can also find out about relevant InVivo Communications Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record